CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
UVA1 radiation treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01776190
NCT01776190N/ACompleted

Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Ben Chong·interventional·Posted Jan 28, 2013·Updated Aug 25, 2023

In Brief

A clinical study evaluating UVA1 radiation treatment for Cutaneous Lupus Erythematosus. Completed, enrolled 6 participants across 1 site.

Detailed Summary

The investigators are conducting an open-label clinical trial determining the effects of UVA1 phototherapy on cutaneous lupus (CLE) patients. Past research on systemic lupus (SLE) subjects indicates that this treatment is likely to be effective in treating cutaneous lupus with few side effects. The fact that most CLE patients are seen at dermatology clinics also increases the usefulness of this study because there is a large probability that phototherapy treatment will be accessible for many of the patients that stand to benefit from it.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsDaavlin Corporation

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 28, 2013
Enrollment StartSep 1, 2012
Primary CompletionSep 1, 2022
TodayJul 2, 2026
Enrollment to primary: 10 yearsPosted 13.4 years ago

Interventions

UVA1 radiation treatmentdevice